EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Jia-You Fang, Kuo-Yen Huang, Tong-Hong Wang, Zih-Chan Lin, Chin-Chuan Chen, Sui-Yuan Chang, En-Li Chen, Tai-Ling Chao, Shuenn-Chen Yang, Pan-Chyr Yang, Chi-Yuan Chen

Journal of Nanobiotechnology · 12.04.2024 · 22 (1)

DOI: 10.1186/s12951-024-02435-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 12.04.2024. Verfasst von Jia-You Fang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyua…. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chang Gung Memorial Hospital, Ministry of Science and Technology of Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Angiotensin-converting enzyme 2 (ACE2) and AXL tyrosine kinase receptor are known to be involved in the SARS-CoV-2 entry of the host cell. Therefore, targeting ACE2 and AXL should be an effective strategy to inhibit virus entry into cells. However, developing agents that can simultaneously target ACE2 and AXL remains a formidable task. The natural compound quercetin has been shown to inhibit AXL expression. Materials and methods In this study, we employed PLGA nanoparticles to prepare nanoparticles encapsulated with quercetin, coated with ACE2-containing cell membranes, or encapsulated with quercetin and then coated with ACE-2-containing cell membranes. These nanoparticles were tested for their abilities to neutralize or inhibit viral infection.

Results

Our data showed that nanoparticles encapsulated with quercetin and then coated with ACE2-containing cell membrane inhibited the expression of AXL without causing cytotoxic activity. Nanoparticles incorporated with both quercetin and ACE2-containing cell membrane were found to be able to neutralize pseudo virus infection and were more effective than free quercetin and nanoparticles encapsulated with quercetin at inhibition of pseudo virus and SARS-CoV-2 infection.

Conclusions

We have shown that the biomimetic nanoparticles incorporated with both ACE-2 membrane and quercetin showed the most antiviral activity and may be further explored for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NanoparticlesHumansAngiotensin-Converting Enzyme 2QuercetinSARS-CoV-2

Stichwörter der Autor:innen

ACE2AXLCOVID-19NanoparticlesQuercetin

Substanzen

Angiotensin-Converting Enzyme 2Quercetin

Autor:innen und Institutionen

  • Research Center for Food and Cosmetic Safety and Research Center for Chinese Herbal Medicine, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
  • Graduate Institute of Natural Products, Chang Gung University, Taoyuan, Taiwan.
  • Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • National Taiwan University YongLin Institute of Health, Taipei, Taiwan.
  • Graduate School of Advanced Technology (Program for Precision Health and Intelligent Medicine), National Taiwan University, Taipei, Taiwan.

Förderung

  • National Science and Technology Council
  • Chang Gung Memorial Hospital
  • Ministry of Science and Technology of Taiwan
  • Chang Gung University of Science and Technology

Zitieren

APA

Fang, J. Y., Huang, K. Y., Wang, T. H., Lin, Z. C., Chen, C. C., Chang, S. Y., Chen, E. L., Chao, T. L., Yang, S. C., Yang, P. C., & Chen, C. Y. (2024). Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02435-2

Vancouver

Fang JY, Huang KY, Wang TH, Lin ZC, Chen CC, Chang SY, et al. Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02435-2

BibTeX
@article{Fang2024,
  author = {Fang, Jia-You and Huang, Kuo-Yen and Wang, Tong-Hong and Lin, Zih-Chan and Chen, Chin-Chuan and Chang, Sui-Yuan and Chen, En-Li and Chao, Tai-Ling and Yang, Shuenn-Chen and Yang, Pan-Chyr and Chen, Chi-Yuan},
  title = {Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12951-024-02435-2}
}
Kostenlos starten →